Title for MeetingAbstracts
Alphabetical listing of titles
-
Antiviral activity of amprenavir in combination with zidovudine/3TC in plasma and CSF in patients with HIV infection. Neuroscience of HIV Infection.
-
Antiviral Activity of Emtricitabine in a Phase I/II Dose Escalation Trial, FTCB-101.
-
Antiviral activity of HIV-1 PR inhibitors in early phase.
-
Antiviral activity of HIV-1 protease inhibitors that combine noncoded D-amino acids with a high affinity isostere.
-
Antiviral activity of hydroxyurea and protease inhibitors in different cell types and their role in HAART.
-
Antiviral activity of indinavir (IDV) plus zidovudine (ZDV) compared to IDV or ZDV alone in antiretroviral naive patients.
-
Antiviral activity of L-735,524, an HIV protease inhibitor, in infected patients.
-
Antiviral activity of lipid prodrugs of foscarnet and ganciclovir against the AD169 and Toledo strains of human cytomegalovirus. Eleventh International Conference on Antiviral Research.
-
Antiviral activity of n-docosanol against HIV and influenza A.
-
Antiviral activity of nevirapine at 400 mg in p24 antigen positive adults. ACTG 164 and 168 Study Teams.
-
Antiviral activity of poly I:poly C12U as monotherapy in early HIV infection and in combination with antiretrovirals (ARV) in treatment experienced patients failing HAART.
-
Antiviral activity of poly(A).poly(U) against HIV in vitro.
-
Antiviral activity of racemates and enantiomers of novel 5- substituted-2',3'-dideoxy-3'-thiacytidine.
-
Antiviral activity of RD6-2198 against intravaginal infection with herpes simplex virus type 2 in mice. Eleventh International Conference on Antiviral Research.
-
Antiviral activity of ribonucleotide reductase inhibitors Didox and Trimodox in the murine immunodeficiency (MULV) MAIDS model: alone or in combination with ddI.
-
Antiviral Activity of Tenofovir (PMPA) against Nucleoside-Resistant HIV Samples.
-
Antiviral activity of the next generation NNRTI TMC125 against a panel of site-directed mutants encompassing mutations observed in vitro and in vivo.
-
Antiviral activity of the plant compound fagaronine chloride, a reverse transcriptase inhibitor in HIV-infected peripheral blood mononuclear cells and T cell lines.
-
Antiviral activity of the protease inhibitor KNI-272 in vivo in the HIV-infected HuPBMC-SCID mouse model.
-
Antiviral Activity of TMC125 against a Panel of Site-directed Mutants Encompassing Mutations Observed in vitro and in vivo.
-
Antiviral Activity of UIC-94-003, a Novel Inhibitor of the Human Immunodeficiency Virus Type 1 Protease.
-
Antiviral activity profiling of the furopyridine-thiopyrimidine, PNU-142721: a novel, potent, HIV-1 non-nucleoside reverse transcriptase inhibitor. Eleventh International Conference on Antiviral Research.
-
Antiviral Activity, Safety, and Tolerability of a Novel, Oral Small-molecule HIV-1 Attachment Inhibitor, BMS-488043, in HIV-1-infected Subjects.
-
Antiviral activity, safety, and tolerability of emivirine (coactinon, EMV, MKC-442) in a protease inhibitor-sparing regimen with two nucleoside reverse transcriptase inhibitors (NRTI) in treatment naive patients: pooled analysis of three controlled clinical trials through 24 weeks.
-
Antiviral activity, safety, and tolerability of Emivirine (EMV, Coactinon) + Stavudine (d4T, Zerit(tm)) + Lamivudine (3TC, Epivir) in treatment-naive HIV-infected volunteers (MKC-301).
-
Antiviral activity, safety, and tolerability of emivirine (EMV, Coactinonreg) in combination with stavudine (Zerit(tm), d4T) + Didanosine (Videx, ddI).
-
Antiviral Activity, Tolerance and Pharmacokinetics of Indinavir with Two Doses of Ritonavir as Salvage Therapy in Children.
-
Antiviral agent glycyrrhizin stimulates human cytomegalovirus replication in retinal pigment epithelial cell. Eleventh International Conference on Antiviral Research.
-
Antiviral agents reduce viral load and delay the detection of infected cells in vivo in the HIV-infected Hu-PBMC SCID mouse model.
-
ANTIVIRAL AND IMMUNOLOGICAL BENEFITS IN HIV PATIENTS RECEIVING PEPTIDE T: FLUSHING OF VIRAL RESERVOIRS.